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Introduction:
Estimation of effective sample size (N/arm) is important to ensure power to detect significant treatment effects. 
However, traditional parametric sample size estimations depend upon restrictive assumptions that often do not 
hold in real data. This study estimates N to detect changes in length of mechanical ventilation (LoMV) using 
Monte-Carlo Simulation (MCS) and mechanical ventilation (MV) data to better simulate the cohort. 
Methods:
Data from 2534 MV patients admitted to Christchurch Hospital ICU from 2011-13 were used. N was estimated 
using MCS to determine a sample size with power of 80%, and compared to the Altman’s nomogram for two 
patients groups, 1)all patients and 2)targeted patients with 1<LoMV≤15 days. MCS allows any range of 
intervention effect to be simulated, where this study tested a 10 and 25% difference in LoMV (0.5–1.25 days for 
mean LoMV of 5 days). The simulated LoMV for the intervention group is compared to the LoMV in a control 
group using the one-sided Wilcoxon Ranksum Test, Student T-Test, and Kolmogorov-Smirnov test to assess 
central tendency and variation. 
Results:
The distribution of LoMV is heavily skewed. Altman’s nomogram assumes a normal distribution and found 
N>1000 to detect a 25% LoMV change. Panels (1-2) show N for 80% power if all patients were included, and 
Panels (3-4) when for the targeted patient group. Panels (1) and (3) show that it is impossible to achieve 80% 
power for a 10% intervention effect. For 25% effect, MSC found N=400/arm (all patients) and N=150/arm 
(targeted cohort). 
Conclusions:
Traditional parametric sample size estimation may over-estimate the required patients. MCS can estimate 
effective N/arm and evaluate specific patient groups objectively, capturing local clinical practice and its impact 
on LoMV. It is important to consider targeting specific patient groups by applying patient selection criteria that 
can be easily translated into trial design. 
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